SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob beck who wrote (2647)7/9/1999 8:12:00 PM
From: Joe  Read Replies (2) of 4140
 
Bob, no, there is no feedback. When I looked back in Edgar at all KERA's S-8's to get the dates, I was reminded that one of the reasons I sold my KERA stock was because KERA management was caught off guard by the speedy approval by FDA.

I went to ASCRS and found that KERA had not been prepared for approval so quickly. They had no prepared materials, booth signage, etc. showing that they had approval. Later during the conference, they had signs hand printed that said they received approval. Needless to say I was disappointed in management. I guess they weren't boy scouts as kids or they forgot the motto.

I have not had enough time to spend watching my stocks this week. So I can't really comment on LCAV. The bottom line with LCAV though is that I think the numbers are going to be better than expected and I will be holding the stock for the long term. Now that options are trading, I will be looking at them.

Regards,

Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext